Bridgeway Capital Management, LLC Exact Sciences Corp Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $1.84 Million - $2.76 Million	27,900 Added 129.17%	49,500 $3.38 Million
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $1.35 Million - $2.05 Million	21,600 New	21,600 $2.03 Million
Q3 2020 Nov 16, 2020	SELL	$72.92 - $102.01 $1.69 Million - $2.37 Million	-23,200 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$55.75 - $92.75 $195,125 - $324,625	-3,500 Reduced 13.11%	23,200 $2.02 Million
Q1 2020 May 15, 2020	BUY	$37.9 - $104.44 $132,650 - $365,540	3,500 Added 15.09%	26,700 $1.55 Million
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $1.8 Million - $2.31 Million	23,200 New	23,200 $2.15 Million

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.1B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.